Drug General Information
Drug ID
D0O1UZ
Former ID
DNC000386
Drug Name
Cannabidiol
Synonyms
cannabidiol; 13956-29-1; (-)-Cannabidiol; (-)-trans-Cannabidiol; Epidiolex; UNII-19GBJ60SN5; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; delta1(2)-trans-Cannabidiol; (-)-CBD; GWP42003-P; CBD; 19GBJ60SN5; QHMBSVQNZZTUGM-ZWKOTPCHSA-N
Drug Type
Small molecular drug
Indication Dravet syndrome [ICD-11: 8A61.11] Approved [1]
LennoxGastaut syndrome [ICD-11: 8A62.1] Approved [1]
Company
GW Pharmaceuticals
Structure
Download
2D MOL

3D MOL

Formula
C21H30O2
Canonical SMILES
CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O
InChI
1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
InChIKey
QHMBSVQNZZTUGM-ZWKOTPCHSA-N
CAS Number
CAS 145514-04-1
PubChem Compound ID
PubChem Substance ID
ChEBI ID
CHEBI:69478;
SuperDrug ATC ID
J05AB04
SuperDrug CAS ID
cas=036791045
Target and Pathway
Target(s) Cannabinoid receptor (CB) Target Info Binder [2]
References
REF 1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
REF 2 (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. Eur J Pharmacol. 2002 Dec 5;456(1-3):99-106.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.